Jeffrey H. Buchalter

2008

In 2008, Jeffrey H. Buchalter earned a total compensation of $4M as Former President and Chief Executive Officer at Enzon Pharmaceuticals, a 24% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$1,111,500
Salary$853,271
Stock Awards$1,864,000
Other$178,974
Total$4,007,746

Buchalter received $1.9M in stock awards, accounting for 47% of the total pay in 2008.

Buchalter also received $1.1M in non-equity incentive plan, $853.3K in salary and $179K in other compensation.

Rankings

In 2008, Jeffrey H. Buchalter's compensation ranked 1,138th out of 9,135 executives tracked by ExecPay. In other words, Buchalter earned more than 87.5% of executives.

ClassificationRankingPercentile
All
1,138
out of 9,135
88th
Division
Manufacturing
413
out of 3,436
88th
Major group
Chemicals And Allied Products
80
out of 815
90th
Industry group
Drugs
50
out of 597
92nd
Industry
Biological Products, Except Diagnostic Substances
9
out of 118
92nd
Source: SEC filing on April 8, 2011.

Buchalter's colleagues

We found five more compensation records of executives who worked with Jeffrey H. Buchalter at Enzon Pharmaceuticals in 2008.

2008

Craig Tooman

Enzon Pharmaceuticals

Chief Financial Officer

2008

Ivan Horak

Enzon Pharmaceuticals

Chief Scientific Officer

2008

Ralph del Campo

Enzon Pharmaceuticals

Chief Operating Officer

2008

Paul Davit

Enzon Pharmaceuticals

Executive Vice President, Human Resources and Administration

2008

Mark Ogden

Enzon Pharmaceuticals

Acting Vice President, Finance and Principal Financial Officer

You may also like